Bailard »

Protara Therapeutic shares owned by Bailard

Quarter-by-quarter ownership of Protara Therapeutic (TARA) shares owned by Bailard from 13F filings

Historical chart of Bailard investment in Protara Therapeutic

Tip: Access up to 7 years of quarterly data

All positions including Protara Therapeutic held by Bailard consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protara Therapeutic by Bailard

Quarter filed Position value Share count Share price at filing
2025-09-30 $160k 37k 4.35
2025-06-30 $90k 30k 3.03
2025-03-31 $127k 30k 4.26
2024-12-31 $157k 30k 5.28

More positions owned by Bailard

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Msci Eafe Etf (EFA)
Alphabet Cap Stk Cl A (GOOGL)
Spdr Gold Tr Gold Shs (GLD)
Vanguard World Inf Tech Etf (VGT)
Ishares Tr Calif Mun Bd Etf (CMF)
Gilead Sciences (GILD)
Ishares Tr Ibonds 26 Trm Ts (IBTG)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds Total Stk Mkt (VTI)
J P Morgan Exchange Traded F Mortgage Backed (JMTG)

View all positions for Bailard

Top funds holding Protara Therapeutic

Henderson Group
BlackRock
Velan Capital Investment Management
Blackstone Group
Vanguard Group
Acorn Capital Advisors
Catalio Capital Management
Integral Health Asset Management
UBS Group
5AM Venture Management
Geode Capital Management
Millennium Management
Baker Bros. Advisors
Citadel Advisors
Driehaus Capital Management

View all funds holding Protara Therapeutic